Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

HARBOR: ABBV-916 In Subjects With Early Alzheimer’s Disease Combined Multiple-Ascending Dose/Proof-Of-Concept Study Design

Author:Watson, David   Lynch, Shau Yu   Florian, Hana   Wang, Deli   Bachhav, Sagar   Boiser, Joey   Bannon, Anthony   Stage, Edwin   Graff, Ole   

Session Name:P7: Aging and Dementia: Therapeutics 1  

Topic:Aging and Dementia  

Program Number:P7.008  

Author Institution:Alzheimer's Research and Treatment Center, Wellington, FL  Neuroscience Clinical Development, AbbVie Inc., North Chicago, IL  Statistics, AbbVie Inc., Buffalo Grove, IL  Clinical Pharmacology, AbbVie Inc., North Chicago, IL  Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL  Precision Medicine, AbbVie Inc., North Chicago, IL  Discovery, AbbVie Inc., North Chicago, IL  

Rates and Predictors of Serious Infections in MS and NMOSD Patients treated with Anti-CD20 Therapy

Author:Abboud, Hesham   Mears, Veronica   Jakubecz, Collin   Serra, Alessandro   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.008  

Author Institution:University Hospitals Cleveland Medical Center, Cleveland, OH  University Hospitals Cleveland Medical Center, Warrensville Heights, OH  

A Quantifiable Telemedicine Approach to the Myasthenia Gravis Neurological Exam

Author:Garbey, Marc   Joerger, Guillaume   Lesport, Quentin   Girma, Helen   McKnett, Sienna   Abu-Rub, Mohammad   Kaminski, Henry   

Session Name:P7: Neuromuscular Disease: Neuromuscular Junction Disorders 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.008  

Author Institution:George Washington University – School of Medicine & Health Sciences, Houston, TX  ORintelligence LLC, Houston, TX  George Washington University – School of Medicine & Health Sciences, Washington, DC  George Washington University, Washington, DC